BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29324814)

  • 21. [Olfactory neuroblastoma with unusual structures: a clinical pathologic study].
    Yao Q; Yue CL; Lü ZC; Han YD; Liu HG
    Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):163-8. PubMed ID: 19575850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative genomic hybridization on microarray (a-CGH) in olfactory neuroblastoma: Analysis of ten cases and review of the literature.
    Valli R; De Bernardi F; Frattini A; Volpi L; Bignami M; Facchetti F; Pasquali F; Castelnuovo P; Maserati E
    Genes Chromosomes Cancer; 2015 Dec; 54(12):771-5. PubMed ID: 26355525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive cytogenetic characterization of an esthesioneuroblastoma.
    Holland H; Koschny R; Krupp W; Meixensberger J; Bauer M; Kirsten H; Ahnert P
    Cancer Genet Cytogenet; 2007 Mar; 173(2):89-96. PubMed ID: 17321323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Results of salvage therapy after failure of initial treatment for advanced olfactory neuroblastoma.
    Kim HJ; Cho HJ; Kim KS; Lee HS; Kim HJ; Jung E; Yoon JH
    J Craniomaxillofac Surg; 2008 Jan; 36(1):47-52. PubMed ID: 18312791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calretinin staining facilitates differentiation of olfactory neuroblastoma from other small round blue cell tumors in the sinonasal tract.
    Wooff JC; Weinreb I; Perez-Ordonez B; Magee JF; Bullock MJ
    Am J Surg Pathol; 2011 Dec; 35(12):1786-93. PubMed ID: 22020045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating the prognostic potential of the Ki67 proliferation index and tumour-infiltrating lymphocytes in olfactory neuroblastoma.
    Classe M; Burgess A; El Zein S; Wassef M; Herman P; Mortuaire G; Leroy X; Malouf GG; Verillaud B
    Histopathology; 2019 Dec; 75(6):853-864. PubMed ID: 31306501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SSTR2 Expression in Olfactory Neuroblastoma: Clinical and Therapeutic Implications.
    Cracolici V; Wang EW; Gardner PA; Snyderman C; Gargano SM; Chiosea S; Singhi AD; Seethala RR
    Head Neck Pathol; 2021 Dec; 15(4):1185-1191. PubMed ID: 33929681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytopathologic features of olfactory neuroblastoma.
    Mahooti S; Wakely PE
    Cancer; 2006 Apr; 108(2):86-92. PubMed ID: 16456848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aggressive esthesioneuroblastoma with divergent differentiation: A taxonomic dilemma.
    Charles NC; Petris CK; Kim ET
    Orbit; 2016 Dec; 35(6):357-359. PubMed ID: 27715372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target.
    Lee MJ; Kim N; Choung HK; Choe JY; Khwarg SI; Kim JE
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):125-33. PubMed ID: 26141290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absence of Epstein-Barr virus in olfactory neuroblastoma.
    Wang SL; Li SH; Chen WT; Chai CY
    Pathology; 2007 Dec; 39(6):565-6. PubMed ID: 18027259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OTX1 and OTX2 as possible molecular markers of sinonasal carcinomas and olfactory neuroblastomas.
    Pirrone C; Chiaravalli AM; Marando A; Conti A; Rainero A; Pistochini A; Lo Curto F; Pasquali F; Castelnuovo P; Capella C; Porta G
    Eur J Histochem; 2017 Feb; 61(1):2730. PubMed ID: 28348423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cytologic features of sinonasal undifferentiated carcinoma and olfactory neuroblastoma.
    Bellizzi AM; Bourne TD; Mills SE; Stelow EB
    Am J Clin Pathol; 2008 Mar; 129(3):367-76. PubMed ID: 18285258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Durable Major Response With Pazopanib in Recurrent, Heavily Pretreated Metastatic Esthesioneuroblastoma Harboring a Fumarate Hydratase Mutation.
    Spengler M; Wheelden M; Mackley HB; Drabick JJ
    JCO Precis Oncol; 2021; 5():. PubMed ID: 34036225
    [No Abstract]   [Full Text] [Related]  

  • 35. CGH pattern of esthesioneuroblastoma and their metastases.
    Bockmühl U; You X; Pacyna-Gengelbach M; Arps H; Draf W; Petersen I
    Brain Pathol; 2004 Apr; 14(2):158-63. PubMed ID: 15193028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The genomics and epigenetics of olfactory neuroblastoma: A systematic review.
    Kaur RP; Izumchenko E; Blakaj DM; Mladkova N; Lechner M; Beaumont TL; Floudas CS; Gallia GL; London NR
    Laryngoscope Investig Otolaryngol; 2021 Aug; 6(4):721-728. PubMed ID: 34401496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy and prognosis of intracranial invasive olfactory neuroblastoma.
    Jiang GY; Li FC; Chen WK; Liu AM; Cai WQ
    Otolaryngol Head Neck Surg; 2011 Dec; 145(6):951-5. PubMed ID: 21825099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor profiling of gastric and esophageal carcinoma reveal different treatment options.
    Miura JT; Xiu J; Thomas J; George B; Carron BR; Tsai S; Johnston FM; Turaga KK; Gamblin TC
    Cancer Biol Ther; 2015; 16(5):764-9. PubMed ID: 25778705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of sonic hedgehog signaling pathway in olfactory neuroblastoma.
    Mao L; Xia YP; Zhou YN; Dai RL; Yang X; Wang YJ; Duan SJ; Qiao X; Mei YW; Hu B
    Oncology; 2009; 77(3-4):231-43. PubMed ID: 19738389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study on pathological features and diagnosis, differential diagnosis of olfactory neuroblastoma].
    Liu HG; Zhang SZ; He CY
    Zhonghua Bing Li Xue Za Zhi; 2003 Oct; 32(5):432-6. PubMed ID: 14633455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.